Organization | Dalin Tzu Chi General Hospital

Dalin Tzu Chi General Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Hualien City Taiwan (2000)

Organization Overview

First Clinical Trial

2011

NCT01579630

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Buddhist Dalin Tzu Chi Hospital | Dalin Tzu Chi General Hospital | Dalin Tzu Chi Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

tenofovir alafenamide (genvoya) (2 trials)

Drugs in Phase 3 Trials (2)

gefitinib (iressa) (1 trial)

pemetrexed (alimta) (1 trial)

Drugs in Other Trials (6)

meperidine (demerol) (2 trials)

polyethylene glycol (1 trial)

pomegranate (1 trial)

resveratrol (1 trial)

sodium chloride (1 trial)

sodium picosulfate (Preopik) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 9